Search company, investor...

Lief Therapeutics

getlief.com

Founded Year

2011

Stage

Incubator/Accelerator - III | Alive

Total Raised

$250K

About Lief Therapeutics

Lief Therapeutics offers an ultra-thin wearable patch that measures users' heart and breath. Lief teaches users to control their body's natural stress response through gentle, safe biofeedback exercises.

Headquarters Location

2443 Fillmore St #380-6060

San Francisco, California, 94115,

United States

Missing: Lief Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

ESPs containing Lief Therapeutics

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Healthcare Providers Tech

The companies in this market develop digital therapeutics to help users manage stress and build mental resilience. These digital therapeutic solutions incorporate mobile CBT apps, virtual reality tech, and wearable sensors.

Lief Therapeutics named as Challenger among 10 other companies, including Twill, meQuilibrium, and BehaVR.

Missing: Lief Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Lief Therapeutics

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Lief Therapeutics in 2 CB Insights research briefs, most recently on May 24, 2021.

Expert Collections containing Lief Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lief Therapeutics is included in 8 Expert Collections, including Digital Health.

D

Digital Health

13,529 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)

M

Mental Health Tech

1,271 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.

V

Value-Based Care & Population Health

890 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.

B

Beauty & Personal Care

858 items

These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.

M

Medical Devices

8,606 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

T

Telehealth

2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Lief Therapeutics Patents

Lief Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Body shape
  • Brassieres
  • Lingerie
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/22/2018

Brassieres, Body shape, Lingerie, Progress (spacecraft) missions, Undergarments

Application

Application Date

2/22/2018

Grant Date

Title

Related Topics

Brassieres, Body shape, Lingerie, Progress (spacecraft) missions, Undergarments

Status

Application

Latest Lief Therapeutics News

ECG Sensor Patch Market to Boom Worldwide Growth 2022-2028 | Medtronic, Lief Therapeutics Vivalnk, LifeSignals

Oct 12, 2022

| Medtronic, Lief Therapeutics Vivalnk, LifeSignals News Provided By Share This Article SEATTLE, UNITED STATES, UNITED STATES, October 12, 2022 / EINPresswire.com / -- Overview: The ECG sensor patch is a diagnostic tool that healthcare professionals use to diagnose atrial fibrillation. This tool aids in the early detection of disease and ensures that the patient receives appropriate care. The sensor is used to monitor multiple cardiac parameters in individuals with heart disease. This is a wearable patch that continuously records the user's ECG, which aids in the detection and management of arrhythmia. This patch also alerts the patient to their level of stress. The global ECG Sensor Patch market generated $14.4 million in 2021 and is projected to reach $299.3 billion by 2028, growing at a CAGR of 43.7% over the forecast period (2022 – 2028). Request More Information on this Report (Including Full TOC, Table & Figures) Drivers: Rising product launch and approvals from key players is estimated to propel growth of the global ECG sensor patch market during the forecast period. For instance, VitalConnect declared that it has received 510(k) clearance from the U.S. FDA, in December 2017. This clearance is received for its wearable biosensor VitalPatch, now it can be worn for 4-5 days. Moreover, at the Consumer Electronics Show, in January 2019, a smart patch was launched by Lief Therapeutics. This patch uses haptic biofeedback technology which helps users in managing, detecting and curing their stress in real-time. Furthermore, increasing investments by the key players and several organizations is estimated to augment growth of the global ECG sensor patch market over the forecast period. For instance, Cardiac Insight, Inc. collected US$ 4.5 Mn funding from various organization for the distribution, sales and production of ECG heartbeat sensor called as Cardea SOLO device, in September 2017. Similarly, Kenzen and Stanford University gained US$ 5 million funding for developing, supporting and marketing of the ECHO Smart Patch wearable technology in 2017. This device measures vital signs of athletes and avoids illness and injuries. Moreover, increasing incidences of atrial fibrillation is anticipated to fuel growth of the global ECG sensor patch market over the forecast period. For instance, the Centers for Disease Control and Prevention (CDC) mentioned that owing to atrial fibrillation more than 750,000 hospitalizations and 130,000 deaths took place in 2017 in the U.S. Key players are focusing on strategies like acquisitions and partnerships for expanding their product portfolio. Medtronic Plc. Acquired EPIX Therapeutics, Inc. in January 2019. This acquisition aims to expand the cardiac ablation portfolio of Medtronic’s. Similarly, LifeSignals, Inc., Dreamtech and INQCEL collaborated for supporting the manufacturing and development of a wearable biosensor, in June 2018. The following Key Players are Mentioned in this Document: Lief Therapeutics Vivalnk, Inc., Medtronic Plc., LifeSignals, Inc., Hill-Rome Holdings, Inc., VitalConnect, iRhythm Technologies, Inc., Cardiac Insight Inc. and AliveCor, Inc. ECG Sensor Patch Market: Segmentation By Product Type: North America (U.S., Canada) Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA) (*NOTE: To get customization to your liking you can ADD / REMOVE Key Players, Regions, and any other Segments as you need.) Click the link to PDF Brochure with Latest Insights How Covid 19 Affected the ECG Sensor Patch Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Impact ECG Sensor Patch market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations, travel bans, and quarantines, restaurants closed, all indoor/outdoor events restricted, over forty countries’ state of emergency declared, massive slowing of the supply chain, stock market volatility, falling business confidence, growing panic among the population, and uncertainty about future. In this segment, we will give you the impact of COVID-19, how it affected the ECG Sensor Patch market, and how it will change the industry’s future depending on the current government, private, and public situations. Our expert analysts keep an open eye on every situation that may change the flow of the industry which will help you make the best possible decision for your enterprise. The objective of the study is to define the ECG Sensor Patch market sizes of different segments and countries in previous years and to forecast the values for the next five years. The report is designed to incorporate qualified qualitative and quantitative aspects of the industry with respect to each region and country involved in the study. Furthermore, the report also caters the detailed information about crucial aspects such as drivers and restraining factors that will define the future growth of the ECG Sensor Patch market. SPECIAL OFFER (Avail an Up-to 30% discount on this report ) Report Coverage: • Provides a comprehensive understanding of the ECG Sensor Patch market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors, and Porter’s five analysis • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market • Uncovers potential demands in the market • Porter analysis identifies competitive forces within the market • Provides information on the historical and current market size and the future potential of the market • Provides sizes of key regional markets using yardsticks of processes, segments, products, end-user, technology, etc (as applicable) • Highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments, and merger acquisitions Why Choose ECG Sensor Patch Market Report? • Unbiased conclusions and market insights • 24×7 customer service available to address client queries • Highly efficient and experienced team of analysts striving to create top-quality reports • Our reports have facilitated the growth of over 500 companies • A systematic and methodical market research process Enquiry before buying this premium Report About us: Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed to playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. ☛ Contact us:

Lief Therapeutics Frequently Asked Questions (FAQ)

  • When was Lief Therapeutics founded?

    Lief Therapeutics was founded in 2011.

  • Where is Lief Therapeutics's headquarters?

    Lief Therapeutics's headquarters is located at 2443 Fillmore St #380-6060, San Francisco.

  • What is Lief Therapeutics's latest funding round?

    Lief Therapeutics's latest funding round is Incubator/Accelerator - III.

  • How much did Lief Therapeutics raise?

    Lief Therapeutics raised a total of $250K.

  • Who are the investors of Lief Therapeutics?

    Investors of Lief Therapeutics include MedTech Innovator, Project Health, Trend Forward Capital and Plug and Play Accelerator.

  • Who are Lief Therapeutics's competitors?

    Competitors of Lief Therapeutics include Twill, BehaVR, Ksana Health, Mobio Interactive, Feel Therapeutics and 10 more.

Compare Lief Therapeutics to Competitors

Feel Therapeutics Logo
Feel Therapeutics

Feel Therapeutics develops biomarkers and digital therapeutics to change the way mental health is diagnosed, managed, and cared for. The company develops wristbands with integrated sensors that measure a variety of bio-signals. The connected mobile app provides personalized recommendations and coaching to help users improve emotional well-being, as well as physiological and digital biomarkers and metrics. The company is a direct-to-consumer firm that is aimed at patients with Major Depressive Disorder and/or Generalized Anxiety Disorder. The company primarily partners with pharmaceutical companies, to advance their clinical development, RWE, and commercialization strategies. It was formerly known as Myfeel and Sentio Solutions. It was founded in 2015 and is based in San Francisco, California.

BehaVR Logo
BehaVR

BehaVR builds evidence-based, immersive and digital therapeutics. Its suite of therapeutics offers access to treatments on a spectrum across mental wellness and mental and behavioral conditions, including validated treatments for serious mental illness. The company delivers these treatments on an integrated platform that simplifies the patient experience, enables clinician oversight, and generates patient-specific care plans and measurable outcomes. BehaVR was founded in 2016 and is based in Elizabethtown, Kentucky.

Twill Logo
Twill

Twill provides digital therapeutics and care delivery models focused on mental and physical health. It partners with enterprises, pharma companies, and health plans to create new products that help support and manage specific mental and physical conditions. The company was formerly known as Happify Health and Happify. It was founded in 2012 and is based in New York, New York.

Thrive Therapeutic Software Logo
Thrive Therapeutic Software

Thrive Therapeutic Software, dba Thrive and formerly Virtually Free, develops evidence-based apps that enable anybody anywhere access to effective techniques that enable better coping with the stresses of life. It helps prevent, detect early and manage common mental health conditions including depression and anxiety.

Tripp Logo
Tripp

Tripp is a digital wellness company developing immersive experiences and an XR Solution that supports mental wellness, focus, and productivity. It is building a mindful metaverse through a mobile app that compiles hours of meditations, sound frequencies, nature sounds, music, and teachings with beautiful animations to support people wherever they are throughout the day. The company was founded in 2017 and is based in Los Angeles, California.

K
Ksana Health

Ksana Health offers a mental health platform that uses research evidence and technology to deliver mental health care through remote objective behavioral monitoring and adaptive, continuous behavior change support. The company offers both the Effortless Assessment Research System (EARS) mobile research platform for passive data collection and the Vira app for remote patient monitoring and digital therapeutics. The apps are designed for patients as well as health systems, researchers, and practitioners. The company was founded in 2019 and is based in Eugene, Oregon.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.